Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Increase in the frequency of obstructive sleep apnea in elderly people.

Ernst G, Mariani J, Blanco M, Finn B, Salvado A, Borsini E.

Sleep Sci. 2019 Jul-Sep;12(3):222-226. doi: 10.5935/1984-0063.20190081.

2.

[Secondary syphilis with pulmonary involvement].

Campos J, Ernst G, Simionato C, Ferraro M, Vigivich F, Salvado A.

Medicina (B Aires). 2019;79(5):415-418. Spanish.

3.

[Synchronous pulmonary adenocarcinoma and primary lymphoma of lung mucosa-associated lymphoid tissue].

Pascua J, Robaina G, Di Tullio F, Samudio M, Mendez J, Auvieux R, Decima T, Salvado A.

Medicina (B Aires). 2019;79(3):208-211. Spanish.

4.

Impact of Mask Type on the Effectiveness of and Adherence to Unattended Home-Based CPAP Titration.

Blanco M, Ernst G, Salvado A, Borsini E.

Sleep Disord. 2019 Mar 25;2019:4592462. doi: 10.1155/2019/4592462. eCollection 2019.

5.

Patients' preferences and the efficacy of a hybrid model of a minimal contact nasal mask in patients with sleep apnea treated with CPAP.

Blanco M, Jaritos V, Ernst G, Salvado A, Nogueira F, Borsini E.

Sleep Sci. 2018 Jul-Aug;11(4):254-259. doi: 10.5935/1984-0063.20180040.

6.

[Hospital admissions in patients with chronic home ventilation].

Borsini E, Blanco M, Ernst G, Ursino R, Robaina G, Salvado A.

Medicina (B Aires). 2018;78(6):403-409. Spanish.

7.

Performance of questionnaires aimed at detecting sleep disorders in patients attending a hypertension center.

Schiavone M, Ernst G, Blanco M, Avaca H, Acosta AL, Nosetto D, Manuale O, Salvado A, Borsini E.

Clin Exp Hypertens. 2019;41(7):687-691. doi: 10.1080/10641963.2018.1539095. Epub 2018 Nov 29.

PMID:
30497297
8.

Simulated intention-to-treat analysis based on clinical parameters of patients at high risk for sleep apnea derivated to respiratory polygraphy.

Borsini EE, Blanco M, Ernst G, Montenegro P, Salvado A, Nigro C.

Sleep Sci. 2018 May-Jun;11(3):160-165. doi: 10.5935/1984-0063.20180030.

9.

Acute response to 7-day therapy with CPAP in patients with moderate to severe obstructive sleep apnea and cardiac arrhytmia.

Campos J, Ernst G, Blanco M, Cassano A, Tello-Santa-Cruz I, Cáceres-Monié C, Muyran A, Cansonieri R, Salvado A, Borsini E.

Sleep Sci. 2018 Jan-Feb;11(1):49-53. doi: 10.5935/1984-0063.20180011.

10.

Ambulatory positional obstructive sleep apnea syndrome.

Di-Tullio F, Ernst G, Robaina G, Blanco M, Salvado A, Meraldi A, Bosio M, Borsini E.

Sleep Sci. 2018 Jan-Feb;11(1):8-11. doi: 10.5935/1984-0063.20180003.

11.

Signature program: a platform of basket trials.

Slosberg ED, Kang BP, Peguero J, Taylor M, Bauer TM, Berry DA, Braiteh F, Spira A, Meric-Bernstam F, Stein S, Piha-Paul SA, Salvado A.

Oncotarget. 2018 Apr 20;9(30):21383-21395. doi: 10.18632/oncotarget.25109. eCollection 2018 Apr 20.

12.

Respiratory polygraphy monitoring of intensive care patients receiving non-invasive ventilation.

Borsini E, Ernst G, Blanco M, Blasco M, Bosio M, Salvado A, Nigro C.

Sleep Sci. 2017 Jan-Mar;10(1):35-40. doi: 10.5935/1984-0063.20170006.

13.

Prevalence of sleep apnea and cardiovascular risk factors in patients with hypertension in a day hospital model.

Borsini E, Blanco M, Bosio M, Schrappe M, Ernst G, Nosetto D, Gaggioli N, Salvado A, Manuale O, Schiavone M.

Clin Exp Hypertens. 2018;40(3):231-237. doi: 10.1080/10641963.2017.1356841. Epub 2017 Sep 5.

PMID:
28872361
14.

[Non-invasive ventilation in patients with diaphragmatic paralysis. Case report].

Blanco M, Ernst G, Salvado A, Cambursano VH, Borsini E.

Rev Fac Cien Med Univ Nac Cordoba. 2017;74(1):55-59. Spanish.

PMID:
28379133
15.

[Pulmonary alveolar proteinosis: role of GM-CSF Antibodies].

Ernst G, Salvado A, Grynblat P, Tabaj G, Garcia O, Cambursano VH, Young P.

Rev Fac Cien Med Univ Nac Cordoba. 2017;74(1):46-50. Review. Spanish.

PMID:
28379131
16.

"Diagnosis of sleep apnea in network" respiratory polygraphy as a decentralization strategy.

Borsini E, Blanco M, Bosio M, Fernando DT, Ernst G, Salvado A.

Sleep Sci. 2016 Jul-Sep;9(3):244-248. doi: 10.1016/j.slsci.2016.10.009. Epub 2016 Nov 14.

17.

[Fatal interstitial lung disease associated with maximum androgen blockade].

Molina Mancero G, Picón X, Di Tullio F, Ernst G, Dezanzo P, Salvado A, Chertcoff JF.

Rev Med Chil. 2016 Oct;144(10):1356-1359. doi: 10.4067/S0034-98872016001000017. Spanish.

18.

Assessing the impact of educational intervention in patients with hypertension.

Ho TM, Estrada D, Agudo J, Arias P, Capillas R, Gibert E, Isnard MM, Solé MJ, Salvadó A.

J Ren Care. 2016 Dec;42(4):205-211. doi: 10.1111/jorc.12165. Epub 2016 Jul 26.

PMID:
27458081
19.

[Role of sex and age as predictors of an apnea and hypopnea index higher than 5/hour in patients with normal body mass index using respiratory polygraphy].

Borsini E, Ernst G, Bosio M, Blanco M, Blasco M, Salvado A.

Med Clin (Barc). 2016 Oct 7;147(7):293-6. doi: 10.1016/j.medcli.2016.05.022. Epub 2016 Aug 8. Spanish.

PMID:
27423652
20.

Difference between apnea-hypopnea index (AHI) and oxygen desaturation index (ODI): proportional increase associated with degree of obesity.

Ernst G, Bosio M, Salvado A, Dibur E, Nigro C, Borsini E.

Sleep Breath. 2016 Dec;20(4):1175-1183. doi: 10.1007/s11325-016-1330-3. Epub 2016 Mar 30.

PMID:
27026417
21.

Bilateral Bronchiectasis as a Presentation Form of Pulmonary Marginal Zone B-Cell Lymphoma of Bronchus Associated Lymphoid Tissue.

Ernst G, Torres C, Borsini E, Vigovich F, Downey D, Salvado A, Bosio M.

Case Rep Oncol Med. 2015;2015:975786. doi: 10.1155/2015/975786. Epub 2015 Dec 29.

22.

Histidine-rich glycoprotein and idiopathic pulmonary fibrosis.

Ernst G, Dantas E, Sabatté J, Caro F, Salvado A, Grynblat P, Geffner J.

Respir Med. 2015 Dec;109(12):1589-91. doi: 10.1016/j.rmed.2015.10.010. Epub 2015 Oct 27.

23.
24.

Tracheobronchial Tuberculosis Without Lung Involvement.

Campos J, Ernst G, Borsini E, Garcia A, Blasco M, Bosio M, Salvado A.

J Clin Med Res. 2015 Aug;7(8):646-8. doi: 10.14740/jocmr2182w. Epub 2015 Jun 9.

25.

Utility of the STOP-BANG components to identify sleep apnea using home respiratory polygraphy.

Borsini E, Ernst G, Salvado A, Bosio M, Chertcoff J, Nogueira F, Nigro C.

Sleep Breath. 2015 Dec;19(4):1327-33. doi: 10.1007/s11325-015-1174-2. Epub 2015 Apr 24.

PMID:
25903074
26.

The Signature Program: Bringing the Protocol to the Patient.

Kang BP, Slosberg E, Snodgrass S, Lebedinsky C, Berry DA, Corless CL, Stein S, Salvado A.

Clin Pharmacol Ther. 2015 Aug;98(2):124-6. doi: 10.1002/cpt.126. Epub 2015 May 11.

27.

Treatment of polycythemia vera with imatinib mesylate.

Silver RT, Bourla MH, Vandris K, Fruchtman S, Spivak JL, Feldman EJ, Salvado AJ.

Leuk Res. 2012 Feb;36(2):156-62. doi: 10.1016/j.leukres.2011.09.001. Epub 2011 Oct 7.

PMID:
21983176
28.

Poorly differentiated adenocarcinoma arising from a cervical bronchial cyst.

Calzada AP, Wu W, Salvado AR, Lai CK, Berke GS.

Laryngoscope. 2011 Jul;121(7):1446-8. doi: 10.1002/lary.21858. Epub 2011 May 16.

PMID:
21590692
29.

Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway.

Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, Faull KF, Srivatsan ES, Wang MB.

Mol Cancer Ther. 2010 Oct;9(10):2665-75. doi: 10.1158/1535-7163.MCT-10-0064.

30.

A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.

Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, Egorin MJ, Lim K, Cotta CV, Price C, Kalaycio M.

Leuk Res. 2010 Dec;34(12):1622-6. doi: 10.1016/j.leukres.2010.03.021. Epub 2010 Apr 27.

PMID:
20427086
31.

High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses.

Cortes JE, Kantarjian HM, Goldberg SL, Powell BL, Giles FJ, Wetzler M, Akard L, Burke JM, Kerr R, Saleh M, Salvado A, McDougall K, Albitar M, Radich J; Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group.

J Clin Oncol. 2009 Oct 1;27(28):4754-9. doi: 10.1200/JCO.2008.20.3869. Epub 2009 Aug 31.

32.

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.

Reardon DA, Egorin MJ, Desjardins A, Vredenburgh JJ, Beumer JH, Lagattuta TF, Gururangan S, Herndon JE 2nd, Salvado AJ, Friedman HS.

Cancer. 2009 May 15;115(10):2188-98. doi: 10.1002/cncr.24213.

33.

Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis.

Quadrelli SA, Molinari L, Ciallella LM, Bosio M, Salvado A.

Rheumatol Int. 2009 Jul;29(9):995-9. doi: 10.1007/s00296-008-0824-0. Epub 2009 Jan 8.

PMID:
19130059
34.

Phase II open label trial of imatinib in polycythemia rubra vera.

Jones CM, Dickinson TM, Salvado A.

Int J Hematol. 2008 Dec;88(5):489-494. doi: 10.1007/s12185-008-0193-1. Epub 2008 Nov 15.

PMID:
19009241
35.

[New argentine consensus of respiratory rehabilitation 2008].

Sívori M, Almeida M, Benzo R, Boim C, Brassesco M, Callejas O, Capparelli I, Conti E, Díaz M, Draghi J, Franco J, Gando S, Giuliano G, Guida R, Jolly E, Pessolano F, Rabinovich R, Ratto P, Rhodius E, Saadia M, Salvado A, Sobrino E, Victorio C.

Medicina (B Aires). 2008;68(4):325-44. Spanish.

PMID:
18786894
36.

Treatment of complete nasal vestibule stenosis with vestibular stents and mitomycin C.

Salvado AR, Wang MB.

Otolaryngol Head Neck Surg. 2008 Jun;138(6):795-6. doi: 10.1016/j.otohns.2008.02.005. No abstract available.

PMID:
18503859
37.

[Accuracy of spirometry in the diagnosis of pulmonary restriction].

Quadrelli S, Bosio M, Salvado A, Chertcoff J.

Medicina (B Aires). 2007;67(6 Pt 2):685-90. Spanish.

PMID:
18422058
38.

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE 2nd, Friedman AH, Salvado AJ, Friedman HS.

Neuro Oncol. 2008 Jun;10(3):330-40. doi: 10.1215/15228517-2008-003. Epub 2008 Mar 21.

39.

[Lung involvement in systemic sclerosis].

Quadrelli S, Ciallella L, Catalán Pellet AC, Molinari L, Salvado A, Auad C, Spina JC.

Medicina (B Aires). 2007;67(5):429-35. Spanish.

PMID:
18051224
40.

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.

Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA.

J Neurooncol. 2007 May;83(1):53-60. Epub 2007 Jan 24.

PMID:
17245623
41.

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.

Trent JC, Ramdas L, Dupart J, Hunt K, Macapinlac H, Taylor E, Hu L, Salvado A, Abbruzzese JL, Pollock R, Benjamin RS, Zhang W.

Cancer. 2006 Oct 15;107(8):1898-908.

42.

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.

Reardon DA, Egorin MJ, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ, Desjardins A, Sathornsumetee S, Provenzale JM, Herndon JE 2nd, Dowell JM, Badruddoja MA, McLendon RE, Lagattuta TF, Kicielinski KP, Dresemann G, Sampson JH, Friedman AH, Salvado AJ, Friedman HS.

J Clin Oncol. 2005 Dec 20;23(36):9359-68. Erratum in: J Clin Oncol. 2006 Mar 1;24(7):1224. Rich, Jeremy N Sr [corrected to Rich, Jeremy N]; Gururangan, Idharan [corrected to Gururangan, Sridharan].

PMID:
16361636
43.

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

Thomas DA, Faderl S, Cortes J, O'Brien S, Giles FJ, Kornblau SM, Garcia-Manero G, Keating MJ, Andreeff M, Jeha S, Beran M, Verstovsek S, Pierce S, Letvak L, Salvado A, Champlin R, Talpaz M, Kantarjian H.

Blood. 2004 Jun 15;103(12):4396-407. Epub 2003 Oct 9.

PMID:
14551133
44.

Hemifacial microsomia.

Salvado A, Rodriguez K, Guarisco JL.

J La State Med Soc. 2003 May-Jun;155(3):136-41.

PMID:
12873098
45.

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.

Cortes J, Giles F, O'Brien S, Thomas D, Albitar M, Rios MB, Talpaz M, Garcia-Manero G, Faderl S, Letvak L, Salvado A, Kantarjian H.

Cancer. 2003 Jun 1;97(11):2760-6.

46.

[European regulations and the future of mercury sphygmomanometers in the clinical setting].

Vinyoles E, Armengol F, Bayó J, Mengual L, Salvadó A, Pepió JM; Grupo de Hipertensión de la Societat Catalana de Medicina Familiar i Comunitària.

Med Clin (Barc). 2003 Apr 5;120(12):460-3. Spanish. No abstract available.

PMID:
12689554
47.

Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection.

Medina J, Salvadó A, del Pozo A.

Int J Pharm. 2001 Mar 23;216(1-2):1-8.

PMID:
11274800
48.

[Early erythropoietin use for the prevention of anemia in infant premature].

Salvadó A, Ramolfo P, Escobar M, Núñez A, Aguayo I, Standen J, Sánchez L, Cabello A.

Rev Med Chil. 2000 Dec;128(12):1313-7. Spanish.

PMID:
11227239
49.

Use of computational fluid dynamics to assess air distribution patterns in animal rooms.

Morse BC, Reynolds SD, Martin DG, Salvado AJ, Davis JA.

Contemp Top Lab Anim Sci. 1995 Sep;34(5):65-9. No abstract available.

PMID:
16457543
50.

[Our protocols for chronic patients, are they maximalist or realistic?].

de la Figuera M, Salvadó A.

Aten Primaria. 1993 Apr 30;11(7):329-30. Spanish. No abstract available.

PMID:
8499545

Supplemental Content

Loading ...
Support Center